{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:21:46Z","timestamp":1790965306275,"version":"4.1.0"},"reference-count":53,"publisher":"Georg Thieme Verlag KG","issue":"02","funder":[{"name":"NIH\/NIAID","award":["U19AI135964"],"award-info":[{"award-number":["U19AI135964"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP). MRSA pneumonia is associated with significant morbidity and mortality. Several virulence factors allow S. aureus to become an effective pathogen. The polysaccharide intracellular adhesin allows for the production of biofilms, some strains can produce capsular polysaccharides that protect against phagocytosis, microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) allow for colonization of epithelial surfaces, and S. aureus secretes several exotoxins that aid in tissue destruction. The \u03b1-hemolysin exotoxin secreted by S. aureus is one of the most important virulence factors for the bacteria. The diagnosis of MRSA pneumonia can be challenging; the infection may present as a mild respiratory infection or severe respiratory failure and septic shock. Many individuals are colonized with MRSA and thus a positive nasopharyngeal swab does not confirm infection in the lower respiratory tract. The management of MRSA pneumonia has evolved. Historically, vancomycin has been the primary antibiotic used to treat MRSA pneumonia. Over the past decade, prospective studies have shown that linezolid leads to higher rates of clinical cure. Monoclonal antibodies are being studied as potential therapeutic options. MRSA is an important cause of HAP\/VAP; novel diagnostics may facilitate rapid diagnosis of this infection and the available literature should be used to make informed decisions on management.<\/jats:p>","DOI":"10.1055\/s-0041-1740583","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T01:23:41Z","timestamp":1644974621000},"page":"304-309","source":"Crossref","is-referenced-by-count":42,"title":["Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia\/Ventilator-Associated Pneumonia"],"prefix":"10.1055","volume":"43","author":[{"given":"Chiagozie I.","family":"Pickens","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Pulmonary, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Wunderink","sequence":"additional","affiliation":[{"name":"Division of Critical Care, Department of Medicine, Pulmonary, Northwestern University Feinberg School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,2,15]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1378\/chest.128.6.3854","article-title":"Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia","volume":"128","author":"M H Kollef","year":"2005","journal-title":"Chest"},{"issue":"07","key":"ref2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/670991","article-title":"The epidemiology of ventilator-associated pneumonia in a network of community hospitals: a prospective multicenter study","volume":"34","author":"M S Lee","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"07","key":"ref3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3201\/eid0807.010427","article-title":"Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals","volume":"8","author":"S K Fridkin","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1086\/678594","article-title":"Epidemiology of methicillin-resistant Staphylococcus aureus pneumonia in community hospitals","volume":"35","author":"S S Lewis","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"21","key":"ref5","first-page":"1970","article-title":"National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011","volume":"173","author":"R Dantes","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"09","key":"ref6","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1086\/496923","article-title":"Is methicillin resistance associated with a worse prognosis in Staphylococcus aureus ventilator-associated pneumonia?","volume":"41","author":"J-R Zahar","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/jhin.2001.0960","article-title":"MRSA in the critically ill","volume":"48","author":"C Theaker","year":"2001","journal-title":"J Hosp Infect"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.128.3.1414","article-title":"Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia","volume":"128","author":"C A DeRyke","year":"2005","journal-title":"Chest"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/cc4934","article-title":"Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia","volume":"10","author":"A F Shorr","year":"2006","journal-title":"Crit Care"},{"issue":"03","key":"ref10","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/01.CCM.0000201885.57697.21","article-title":"Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy","volume":"34","author":"A F Shorr","year":"2006","journal-title":"Crit Care Med"},{"issue":"05","key":"ref11","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"A C Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1164\/rccm.201708-1717LE","article-title":"Evaluation of the 2016 Infectious Diseases Society of America\/American Thoracic Society Guideline Criteria for risk of multidrug-resistant pathogens in patients with hospital-acquired and ventilator-associated pneumonia in the ICU","volume":"197","author":"P K Ekren","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"e02272","DOI":"10.1128\/mBio.02272-14","article-title":"Differential expression and roles of Staphylococcus aureus virulence determinants during colonization and disease","volume":"6","author":"A Jenkins","year":"2015","journal-title":"MBio"},{"issue":"12","key":"ref14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","article-title":"The role of nasal carriage in Staphylococcus aureus infections","volume":"5","author":"H F Wertheim","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJM200101043440102","article-title":"Nasal carriage as a source of Staphylococcus aureus bacteremia","volume":"344","author":"C von Eiff","year":"2001","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3184\/003685002783238870","article-title":"Methicillin resistance in Staphylococcus aureus: mechanisms and modulation","volume":"85","author":"P D Stapleton","year":"2002","journal-title":"Sci Prog"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1128\/CMR.10.4.781","article-title":"Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications","volume":"10","author":"H F Chambers","year":"1997","journal-title":"Clin Microbiol Rev"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13059-017-1252-9","article-title":"Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice","volume":"18","author":"C P Harkins","year":"2017","journal-title":"Genome Biol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S350","DOI":"10.1086\/533591","article-title":"Pathogenesis of methicillin-resistant Staphylococcus aureus infection","volume":"46","author":"R J Gordon","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1128\/JCM.01572-06","article-title":"Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests","volume":"45","author":"I Verdier","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00281-011-0291-7","article-title":"Immunopathogenesis of Staphylococcus aureus pulmonary infection","volume":"34","author":"D Parker","year":"2012","journal-title":"Semin Immunopathol"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrmicro3161","article-title":"Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus","volume":"12","author":"T J Foster","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"09","key":"ref23","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1128\/AAC.00357-16","article-title":"Staphylococcus aureus alpha-toxin is conserved among diverse hospital respiratory isolates collected from a global surveillance study and is neutralized by monoclonal antibody MEDI4893","volume":"60","author":"D E Tabor","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1128\/mr.55.4.733-751.1991","article-title":"Alpha-toxin of Staphylococcus aureus","volume":"55","author":"S Bhakdi","year":"1991","journal-title":"Microbiol Rev"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.3390\/toxins5061140","article-title":"Staphylococcus aureus \u03b1-toxin: nearly a century of intrigue","volume":"5","author":"B J Berube","year":"2013","journal-title":"Toxins (Basel)"},{"issue":"02","key":"ref26","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/IAI.01313-06","article-title":"Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia","volume":"75","author":"J Bubeck Wardenburg","year":"2007","journal-title":"Infect Immun"},{"issue":"01","key":"ref27","doi-asserted-by":"crossref","first-page":"e00606-17","DOI":"10.1128\/IAI.00606-17","article-title":"Staphylococcus aureus alpha-toxin disrupts endothelial-cell tight junctions via acid sphingomyelinase and ceramide","volume":"86","author":"K A Becker","year":"2017","journal-title":"Infect Immun"},{"issue":"03","key":"ref28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/infdis\/jis192","article-title":"ADAM10 mediates vascular injury induced by Staphylococcus aureus \u03b1-hemolysin","volume":"206","author":"M E Powers","year":"2012","journal-title":"J Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"S241","DOI":"10.1093\/infdis\/jiaa702","article-title":"The lung microbiome and pneumonia","volume":"223","author":"M M Pettigrew","year":"2021","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.coi.2020.03.010","article-title":"Commensal bacteria in the upper respiratory tract regulate susceptibility to infection","volume":"66","author":"S E Clark","year":"2020","journal-title":"Curr Opin Immunol"},{"issue":"03","key":"ref31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0272-5231(21)00800-5","article-title":"The impact of tracheal intubation on host defenses and risks for nosocomial pneumonia","volume":"12","author":"S A Levine","year":"1991","journal-title":"Clin Chest Med"},{"issue":"02","key":"ref32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/AAC.01805-13","article-title":"Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia","volume":"58","author":"B Dangerfield","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"05","key":"ref33","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.chest.2019.02.007","article-title":"Rapid detection of methicillin-resistant Staphylococcus aureus in BAL: a pilot randomized controlled trial","volume":"155","author":"J R Paonessa","year":"2019","journal-title":"Chest"},{"issue":"08","key":"ref34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-132-8-200004180-00004","article-title":"Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial","volume":"132","author":"J Y Fagon","year":"2000","journal-title":"Ann Intern Med"},{"issue":"03","key":"ref35","doi-asserted-by":"crossref","first-page":"1700582","DOI":"10.1183\/13993003.00582-2017","article-title":"International ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)\/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci\u00f3n Latinoamericana del T\u00f3rax (ALAT)","volume":"50","author":"A Torres","year":"2017","journal-title":"Eur Respir J"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1469-0691.2005.01236.x","article-title":"PCR for the identification of methicillin-resistant Staphylococcus aureus (MRSA) strains using a single primer pair specific for SCCmec elements and the neighbouring chromosome-borne orfX","volume":"11","author":"C Cuny","year":"2005","journal-title":"Clin Microbiol Infect"},{"issue":"05","key":"ref37","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/jac\/38.5.865","article-title":"Penetration of vancomycin into human lung tissue","volume":"38","author":"M Cruciani","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1185\/03007990903512057","article-title":"The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid","volume":"26","author":"G E Stein","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"05","key":"ref39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/cir895","article-title":"Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study","volume":"54","author":"R G Wunderink","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"03","key":"ref40","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1186\/cc13914","article-title":"Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study","volume":"18","author":"P Peyrani","year":"2014","journal-title":"Crit Care"},{"issue":"07","key":"ref41","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/phar.1771","article-title":"Comparison of linezolid and vancomycin for methicillin-resistant Staphylococcus aureus pneumonia: institutional implications","volume":"36","author":"M C Tong","year":"2016","journal-title":"Pharmacotherapy"},{"issue":"05","key":"ref42","first-page":"1789","article-title":"Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia","volume":"124","author":"R G Wunderink","year":"2003","journal-title":"Chest"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jgar.2020.12.009","article-title":"Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus","volume":"24","author":"H Kato","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"05","key":"ref46","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/AAC.02371-13","article-title":"Large retrospective evaluation of the effectiveness and safety of ceftaroline fosamil therapy","volume":"58","author":"A M Casapao","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/cid\/ciu219","article-title":"A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia","volume":"59","author":"S S Awad","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"S 61","key":"ref48","first-page":"OA4655","article-title":"Eradication of MRSA ventilator-associated infection with inhaled vancomycin","volume":"50","author":"L B Palmer","year":"2017","journal-title":"Eur Respir J"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12890-018-0588-6","article-title":"Successful eradication of newly acquired MRSA in six of seven patients with cystic fibrosis applying a short-term local and systemic antibiotic scheme","volume":"18","author":"A Kiefer","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"01","key":"ref50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/microorganisms6010025","article-title":"Antibody-based agents in the management of antibiotic-resistant Staphylococcus aureus diseases","volume":"6","author":"P Speziale","year":"2018","journal-title":"Microorganisms"},{"issue":"01","key":"ref51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.4161\/19420862.2014.985132","article-title":"Five birds, one stone: neutralization of \u03b1-hemolysin and 4 bi-component leukocidins of Staphylococcus aureus with a single human monoclonal antibody","volume":"7","author":"H Rouha","year":"2015","journal-title":"MAbs"},{"issue":"11","key":"ref52","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00134-018-5229-2","article-title":"Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial","volume":"44","author":"B Fran\u00e7ois","year":"2018","journal-title":"Intensive Care Med"},{"issue":"09","key":"ref53","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1164\/rccm.201908-1561ED","article-title":"Turning the phage on treatment of antimicrobial-resistant pneumonia","volume":"200","author":"R G Wunderink","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"09","key":"ref54","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1017\/ice.2020.440","article-title":"Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in respiratory cultures and diagnostic performance of the MRSA nasal polymerase chain reaction (PCR) in patients hospitalized with coronavirus disease 2019 (COVID-19) pneumonia","volume":"42","author":"C D Punjabi","year":"2021","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"07","key":"ref56","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3201\/eid2207.151319","article-title":"Increased mortality rates associated with Staphylococcus aureus and influenza co-infection, Maryland and Iowa, USA(1)","volume":"22","author":"J S McDanel","year":"2016","journal-title":"Emerg Infect Dis"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1740583.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T23:55:46Z","timestamp":1650326146000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1740583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,15]]},"references-count":53,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2022,4,18]]},"published-print":{"date-parts":[[2022,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1740583","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,15]]}}}